Clinical features and risk-factors analysis of coexistence of tuberculosis and tumour in the same lesion: a case-control study
This retrospective case-control study of 150 patients at Guangzhou Chest Hospital identifies that elderly patients with coexisting tuberculosis and lung cancer in a single lesion typically present with upper or lower lobe lesions, squamous cell carcinoma pathology, and elevated CEA and CYFRA21-1 levels, distinguishing them from those with isolated tuberculosis or cancer to guide improved differential diagnosis and treatment.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the human body, two very different conditions can sometimes hide in the same place, making them incredibly difficult to tell apart. One is tuberculosis, a serious bacterial infection that attacks the lungs and leaves behind scar tissue as it heals. The other is lung cancer, a disease where cells grow out of control to form a tumor. While these are distinct illnesses, they share many of the same warning signs, such as a lingering cough, chest pain, or blood in the sputum. When a patient has both diseases occurring inside the exact same spot in the lung, the situation becomes a medical puzzle. Doctors often struggle to know whether they are treating an infection or a malignancy, and getting the diagnosis wrong can delay the right treatment, putting the patient's life at risk.
Researchers in China recently set out to solve this specific puzzle by looking at patients who had both tuberculosis and a tumor growing together in a single lung lesion. They gathered data from 150 people treated at a chest hospital between 2020 and 2024. To understand what made these "mixed" cases unique, the team compared them against two other groups: patients who had only tuberculosis and patients who had only lung cancer. By examining their ages, where the spots appeared in the lungs, the type of cancer cells present, and the levels of specific proteins in their blood, the scientists hoped to find a pattern that could help doctors spot this rare combination earlier.
The study revealed that this double diagnosis is not a random occurrence but follows a distinct profile. The patients who had both diseases were significantly older than those with tuberculosis alone, with an average age in their early sixties compared to their early forties. This suggests that the risk of these two conditions merging increases as people get older, likely because the aging immune system becomes less effective at keeping both the bacteria and the cancer cells in check. When the researchers looked at where the lesions were located, a clear difference emerged. The patients with only tuberculosis typically had infections scattered across multiple sections of the lungs or on both sides. In contrast, the patients with both diseases had lesions that were tightly packed into a single area, most often found in the upper or lower parts of the lung.
The type of cancer found in these mixed cases also told a specific story. While lung cancer in the general population is most often a type called adenocarcinoma, the tumors found alongside tuberculosis were more likely to be squamous cell carcinoma, a different variety that makes up nearly half of the cases in this group. This finding points to a specific biological process where the chronic irritation and scarring from the tuberculosis infection might be encouraging this particular type of cancer to grow.
Perhaps the most practical discovery for doctors involves the blood tests used to screen for these conditions. The researchers found that standard markers for inflammation, such as C-reactive protein and procalcitonin, did not help distinguish between the groups because both diseases cause inflammation. However, two specific tumor markers, CEA and CYFRA21-1, behaved differently. In the patients with both diseases, these markers were significantly higher than in those with tuberculosis alone. This suggests that if an older patient has a lung spot that looks like tuberculosis but their levels of these specific proteins are elevated, it is a strong signal that cancer may also be hiding there.
The study concludes that while tuberculosis and lung cancer can look identical on a scan and feel similar to the patient, they leave behind a unique fingerprint when they occur together. By paying attention to the patient's age, the specific location of the lesion, the type of cancer cells, and the levels of certain proteins in the blood, doctors can improve their ability to diagnose this difficult condition. The researchers emphasize that for elderly patients with a single lung spot that does not respond to standard tuberculosis treatment, checking these specific blood markers and performing a biopsy is crucial. This approach offers a clearer path to the right diagnosis, ensuring that patients receive the correct treatment for both the infection and the cancer without the dangerous delays that often accompany this rare coexistence.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.